PDB23 COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR TYPE 2 DIABETES PATIENTS IN A POLISH SETTING
M Aristides, R Kotchie, S Nielsen, C Townsend, WJ Valentine, H ScheijbelerVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64971-6
File:
PDF, 72 KB
english, 2007